A safe and effective malaria vaccine is high on the wish list of most people concerned with global health. New results suggest how a leading vaccine candidate could be vastly improved. A safe and ...
Discover the latest articles and news in related subjects. Here we present results identifying small-molecule inhibitors of AMA1–RON2 interaction that block merozoite invasion of RBCs. We show that ...
An experimental vaccine designed to spur production of antibodies against a key malaria parasite protein, AMA1, was developed more than decade ago. It showed promise in test-tube and animal ...
A protein that plays a critical role in helping malaria parasites infect red blood cells—known as apical membrane protein 1 (AMA1)—has been found to bind to more than one receptor on the surface of ...
Scientists at La Trobe University have discovered a new antibody-like molecule that could be used in therapy to prevent infection from multiple malaria parasite species. Led by Professor Michael Foley ...
Writing in Cell Reports, researchers from the National Institute of Allergy and Infectious Diseases (NIAID) and collaborators have presented a multifaceted analysis and structure-function study of a ...
An experimental vaccine designed to spur production of antibodies against a key malaria parasite protein, AMA1, was developed more than decade ago by scientists from the National Institute of Allergy ...
A safe and effective malaria vaccine is high on the wish list of most people concerned with global health. Results published on December 26 in PLOS Pathogens suggest how a leading vaccine candidate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results